Mind + Muscle

technical minds + legal muscle


dig deep

Proceed With Caution

  • 06.15.14
  • Gaby L. Longsworth, Ph.D. and Eric K. Steffe
  • Life Sciences Intellectual Property Review

Directors Gaby L. Longsworth, Ph.D. and Eric K. Steffe highlight the careful consideration one must make of obviousness-type double patenting, specifically with regard to potential patent term adjustment and patent term extension issues in the biotech and pharma industries. In light of recent rulings from the Federal Circuit, understanding this interplay proves paramount to patent drafting and prosecution.

To read the full article, please download the attached PDF.  

Related People

Related Services

Related Industries

Sort By Media Type

Sort By Media Type
  • AlertAlert
  • BriefsBriefs
  • Comments to USPTOComments to USPTO
  • Design Patent Case DigestDesign Patent Case Digest
  • MultimediaMultimedia
  • News & ArticlesNews & Articles
  • Press ReleasePress Release
  • VideoVideo
  • WebinarWebinar

Unsolicited e-mails and information sent to Sterne, Kessler, Goldstein & Fox P.L.L.C. will not be considered confidential or privileged, may be disclosed to others, may not receive a response, and do not create an attorney-client relationship with Sterne Kessler.  If you are not already a client of Sterne Kessler, do not include any confidential information in this message.